BRGXOTCServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
BIOREGENX, INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026
$0.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $3.88M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Bioregenx's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Suzanne Bird | 92,271,364 | 9.60% | 13D (active) amendment | Mar 8, 2024 |
| Robert Doran | 73,800,000 | 7.71% | 13D (active) amendment | Mar 8, 2024 |
| William Resides | 218,538,944 | 22.84% | 13D (active) amendment | Mar 8, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Richard Janney | Director | – | – | Jan 2, 2025 |